Gary Oderda, Prof., PharmD, MPH
University of Utah, Department of Pharmacotherapy and Program in Personalized Health Care
30 S 2000 E, Rm 4410
Salt Lake City,
UT
USA
84112
Papers:
COST-EFFECTIVENESS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THE UNITED STATES
Student?
yes
SMDM Member?
yes